Vanguard Group Inc. Acquires 1,693,918 Shares of Astera Labs, Inc. $ALAB

Vanguard Group Inc. grew its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 14.1% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,743,141 shares of the company’s stock after purchasing an additional 1,693,918 shares during the period. Vanguard Group Inc. owned about 0.08% of Astera Labs worth $2,690,907,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. State Street Corp grew its holdings in shares of Astera Labs by 39.3% in the second quarter. State Street Corp now owns 2,143,459 shares of the company’s stock worth $193,812,000 after purchasing an additional 604,363 shares during the last quarter. 1832 Asset Management L.P. boosted its position in Astera Labs by 151.4% in the 2nd quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company’s stock valued at $139,563,000 after buying an additional 929,600 shares during the period. Massachusetts Financial Services Co. MA grew its stake in Astera Labs by 46.6% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,507,675 shares of the company’s stock worth $295,203,000 after acquiring an additional 479,360 shares in the last quarter. Geode Capital Management LLC grew its stake in Astera Labs by 36.2% in the 2nd quarter. Geode Capital Management LLC now owns 1,244,978 shares of the company’s stock worth $112,562,000 after acquiring an additional 330,841 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its position in shares of Astera Labs by 0.9% during the second quarter. JPMorgan Chase & Co. now owns 946,092 shares of the company’s stock worth $85,546,000 after acquiring an additional 8,870 shares during the period. 60.47% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Astera Labs

In related news, Director Manuel Alba sold 150,000 shares of the business’s stock in a transaction on Monday, December 1st. The stock was sold at an average price of $166.18, for a total transaction of $24,927,000.00. Following the transaction, the director directly owned 1,574,498 shares in the company, valued at $261,650,077.64. The trade was a 8.70% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 12.50% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. JPMorgan Chase & Co. boosted their price target on Astera Labs from $180.00 to $215.00 and gave the company an “overweight” rating in a report on Wednesday, November 5th. TD Cowen reaffirmed a “hold” rating on shares of Astera Labs in a research report on Wednesday, November 5th. Stifel Nicolaus upped their target price on Astera Labs from $185.00 to $200.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. BNP Paribas Exane started coverage on Astera Labs in a research note on Thursday, November 20th. They set an “outperform” rating on the stock. Finally, Roth Mkm upped their price objective on shares of Astera Labs from $200.00 to $225.00 and gave the stock a “buy” rating in a research note on Wednesday, November 5th. Fourteen equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and a consensus target price of $192.89.

Astera Labs Stock Performance

ALAB stock opened at $129.58 on Thursday. Astera Labs, Inc. has a one year low of $47.13 and a one year high of $262.90. The firm has a market cap of $21.89 billion, a price-to-earnings ratio of 106.21, a PEG ratio of 2.43 and a beta of 1.50. The firm has a 50-day simple moving average of $161.60 and a two-hundred day simple moving average of $174.41.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping the consensus estimate of $0.51 by $0.07. The firm had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.87%. Astera Labs’s revenue was up 91.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, equities analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.